Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2017 | ||||||||
|
progestagen associated endometrial protein | 0.430 | 0.846 | 3.1E-08 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
S100 calcium binding protein A8 | 0.430 | 0.962 | 0.14 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
microRNA 145 | 0.431 | 0.846 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2010 | 2012 | |||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
disease | 0.130 | None | 1.000 | 3 | 0 | 1986 | 2019 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
disease | 0.170 | None | 1.000 | 7 | 0 | 1996 | 2019 | ||||||||
|
transferrin receptor | 0.437 | 0.885 | 7.0E-05 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 1990 | 1990 | ||||||||
|
neurofibromin 1 | 0.440 | 0.885 | 0.90 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1997 | 1997 | ||||||||
|
interferon alpha 2 | 0.442 | 0.885 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1989 | 1989 | |||||||||
|
signal transducer and activator of transcription 5B | 0.442 | 0.808 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
C-C motif chemokine receptor 7 | 0.443 | 0.769 | 5.8E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
signal transducer and activator of transcription 5A | 0.445 | 0.808 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
apolipoprotein B | 0.453 | 0.808 | 1.9E-16 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
thyroid peroxidase | 0.455 | 0.846 | 1.8E-21 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 2004 | 2008 | ||||||||
|
Pulmonary disease, chronic obstructive, severe early-onset | 0.456 | 0.885 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 | |||||||||
|
aquaporin 1 (Colton blood group) | 0.467 | 0.885 | 2.6E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
TNF receptor associated factor 6 | 0.472 | 0.808 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
MOK protein kinase | 0.476 | 0.769 | 8.8E-22 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
mucin 16, cell surface associated | 0.479 | 0.808 | 8.3E-112 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2017 | 2019 | ||||||||
|
synthesis of cytochrome C oxidase 2 | 0.479 | 0.846 | 7.5E-07 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2017 | ||||||||
|
thymidine phosphorylase | 0.495 | 0.769 | 1.2E-04 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2017 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 13 | 0.496 | 0.769 | 5.1E-15 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
MPL proto-oncogene, thrombopoietin receptor | 0.510 | 0.692 | 4.1E-09 |
|
disease | 0.500 | None | 0.957 | 19 | 3 | 2004 | 2018 |